Mounjaro is available on the NHS, but only for a limited group of patients with obesity and a weight-related health condition or type 2 diabetes, and access depends heavily on where you live. Most people will need to meet strict eligibility criteria, enter a specialist treatment pathway or choose to pay for a private prescription.

What Is Mounjaro?

Mounjaro is the brand name for tirzepatide, a once-weekly injection that mimics two gut hormones, GLP-1 and GIP, which reduce appetite and slow digestion. It's licensed in the UK for both type 2 diabetes and weight management and has shown substantial weight loss in clinical trials when combined with diet and exercise.

Dr Hussain Ahmad, Consultant Practitioner at Click2Pharmacy, says the rollout has created widespread confusion about who can actually access it.

'The NHS is currently rolling out Mounjaro in phases; it's not yet a routine prescription for most patients in general practice.'

Who Qualifies for Mounjaro on the NHS?

The NHS England interim commissioning guidance sets out a phased approach, widening access in cohorts over several years rather than opening treatment to everyone who meets the full clinical criteria.

Under the first cohort, patients generally need a BMI of 40 or above (37.5 for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds), plus at least four of five qualifying long-term conditions, including type 2 diabetes, hypertension and obstructive sleep apnoea.

A second cohort, introduced in June 2026, extended access to people with a BMI of 35 to 39.9 who also meet the required comorbidity threshold.

As Dr Ahmad explains, the detail that often catches people out is the combination of requirements.

'The eligibility criteria are often misunderstood, as patients usually need both obesity and a weight-related health condition, not just high BMI.'

For people with type 2 diabetes, Mounjaro is prescribed under separate NICE guidance and is already more established in routine diabetes care, although it remains one treatment option among several rather than an automatic choice.

Can You Get Mounjaro on the NHS for Weight Loss Alone?

In most cases, no.

Although NICE recommends Mounjaro for adults with obesity and at least one weight-related health condition, current NHS England commissioning guidance is more restrictive. Most patients currently need to meet both BMI thresholds and multiple qualifying health conditions before they can access treatment through the NHS.

Simply wanting to lose weight or having a high BMI alone is unlikely to be enough under the current phased rollout.

NICE Guidance Versus What's Actually Available

NICE approved tirzepatide for weight management in December 2024, recommending it for adults with a BMI of 35 or above (32.5 with ethnic adjustment) and at least one weight-related condition.

However, NHS England's active commissioning guidance is narrower than NICE's full clinical recommendation, reflecting the cost and capacity required to roll out treatment to the estimated 3.4 million people who could clinically benefit. NICE has indicated that full implementation could take up to 12 years.

Why Your Local Area Matters

From April 2026, prescribing for weight management was added to the GP contract's Quality and Outcomes Framework, but participation remains optional for individual practices, so availability varies significantly across England.

Integrated care boards (ICBs) also differ in how quickly they've developed specialist weight management services. As a result, two patients with identical BMI and health conditions may face very different waiting times depending on where they live.

Dr Ahmad warns that meeting the clinical criteria does not necessarily mean treatment will begin quickly.

'Access can still be delayed even if these criteria are met, for reasons such as local capacity, waiting lists and phased implementation.'

Can I Ask My GP?

Yes, but the conversation is usually about eligibility and referral pathways rather than receiving an immediate prescription.

Dr Ahmad explains:

'Any conversations that patients have with their GP will usually be about if they qualify for Mounjaro and where they can be referred, rather than getting a prescription straight away.'

Some GP practices have not opted into the prescribing pathway, meaning a referral to a specialist weight management or Tier 3 service may be the only NHS route.

It's also worth remembering that Mounjaro is not intended to be a standalone solution.

Dr Ahmad stresses:

'Mounjaro should only be seen as part of a wider treatment plan, not as a substitute for healthier eating or being more physically active.'

NHS pathways typically require patients to participate in a structured lifestyle support programme alongside medication.

Is There a Waiting List?

Yes, in most areas.

Specialist Tier 3 weight management services have reported waiting times ranging from several months to two or three years, depending on local demand and staffing. Even patients who meet the national eligibility criteria may have to wait until capacity becomes available within their local ICB.

Can You Get Mounjaro Privately?

For people who do not meet NHS eligibility criteria, or who do not want to wait for treatment, a private prescription is a legal alternative.

Private providers typically require a consultation confirming a BMI of 27 to 29.9 or above with a qualifying health condition, making eligibility considerably broader than current NHS thresholds.

Treatment generally costs between £130 and £400+ per month, depending on the prescribed dose, provider and whether consultation or delivery fees are included. Prices increased across much of the market following a 2025 wholesale price rise announced by manufacturer Eli Lilly, meaning long-term treatment can become a significant financial commitment.

However, paying privately does not mean the medication is suitable for everyone. Reputable providers assess a person's medical history, current medications, BMI and underlying health conditions before prescribing Mounjaro. Many also provide ongoing clinical reviews to monitor weight loss, side effects and whether treatment should continue.

Dr Ahmad urges caution before choosing a private provider.

'If anyone is considering a private prescription, they should check that the prescriber is properly registered and that ongoing monitoring is included as well as the injections.'

The General Pharmaceutical Council (GPhC) register can help patients verify whether an online pharmacy is properly regulated.

Experts also advise being cautious of unusually low prices, websites that do not require a medical assessment or sellers offering Mounjaro without a valid prescription, as counterfeit or unregulated medicines may pose serious health risks.

Regulated online pharmacies such as Click2Pharmacy publish their registration details and prescribing processes to help reassure patients that they meet UK regulatory standards.

While Mounjaro is now available on the NHS, access remains limited as treatment is introduced in phases across England. Whether you qualify depends on your BMI, existing health conditions and local NHS services. If you think you may be eligible, speak to your GP or healthcare team, who can advise on local referral pathways and whether Mounjaro is appropriate for your individual circumstances.